About usAbout us
- Broad and maturing pipeline of development programmes
- Track record of successful development, including marketed products
- Strong financial position backed by a growing income stream
- Highly experienced executive and senior management team
One of the UK’s leading development stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from our own research activities, and from successful collaboration with a number of global pharmaceutical businesses. Our pipeline focuses on several key areas of disease in CNS and oncology.
Overview
See where Vernalis is now
View the pipeline, plus our staffing and research capabilities
Vision and strategy
Clear direction for the competitive biotech sector
What therapeutic areas are we targeting, and what strategies do we rely on to achieve results?
Our People
Experienced, successful, engaged leadership
For a company this size, our directors and senior management stand out
History
Where does Vernalis come from?
The history of the organisation, and the relationships we’ve developed
Careers at Vernalis
Interested in working with us?
Check out current vacancies and see the specialisations we are looking for
Corporate Social Responsibility
We take our responsibilities seriously
Good governance and good practice are inherent in all our operations
Latest News
Tuesday, 17 January 2012
Vernalis and Servier Sign Third Oncology Collaboration
Vernalis plc, Servier announce they have entered into a new three-year joint oncology collaboration focused on the discovery of drugs for a new undisclosed target.
Product Pipeline
See at a glance what Vernalis has in development